Timothy Perren

14.6k citations
152 papers · 7.0k · 1 hit paper · h-index 42

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 0.5%
    • Cancer Treatment and Pharmacology
    • PARP inhibition in cancer therapy
    • HER2/EGFR in Cancer Research

Papers in

Timothy Perren

149 papers receiving 6.7k citations

Timothy Perren's Hit Papers

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial 2015 · 986 citations
9860+3+7Years since publication250500750

Peers

Timothy Perren
Comparison fields: 5 of 142
  • Reproductive Medicine 2.0k
  • Oncology 2.4k
  • Obstetrics and Gynecology 470
  • Cancer Research 724
  • Hematology 428
Replace Claire F. Verschraegen with:
Claire F. Verschraegen United States
Linda Mileshkin Australia
R. Kreienberg Germany
Fedro A. Peccatori Italy
Susana Banerjee United Kingdom
Lukas Hefler Austria
Paul Sabbatini United States
Alexander Reinthaller Austria
M. Kaufmann Germany
W. Jonat Germany
Timothy Perren relative to Claire F. Verschraegen United States Claire F. Verschraegen's profile →
Citations per field
00.5×1.5×2.0×
Claire F. Verschraegen · 1×
Citations per year

Countries citing papers authored by Timothy Perren

Since Specialization
Citations

This map shows the geographic impact of Timothy Perren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Perren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Perren more than expected).

Fields of papers citing papers by Timothy Perren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Perren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Perren. The network helps show where Timothy Perren may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy Perren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy Perren Line = papers co-authored together Timothy Perren links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Hit paper breakdown →
2015986
2 2007426
3 1999304
4
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
2000292
5 1993262
6 2011223
7 1987200
8 2011175
9 2016173
10 1997140
11 2005131
12 2016124
13 1991124
14 1998114
15 1995112
16 2003106
17 2001102
18 201399
19 200785
20 201680

About Timothy Perren

Timothy Perren is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 152 papers that have together received 7.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (60 papers), Cancer Treatment and Pharmacology (17 papers), Breast Cancer Treatment Studies (16 papers), Intraperitoneal and Appendiceal Malignancies (15 papers), Renal cell carcinoma treatment (9 papers), Lymphoma Diagnosis and Treatment (9 papers), HER2/EGFR in Cancer Research (7 papers) and Cancer Mechanisms and Therapy (7 papers). The work is most often cited by research in Reproductive Medicine (2.0k citations), Oncology (2.4k citations), Obstetrics and Gynecology (470 citations), Cancer Research (724 citations) and Hematology (428 citations). Timothy Perren has collaborated with scholars based in United Kingdom, Germany and Australia. Frequent co-authors include Peter J. Selby, Gordon C. Jayson, P Selby, Rosamonde E. Banks, Sean Kehoe, Matthew Nankivell, Jane Hook, Mahesh Parmar, Julia Brown and Sharadah Essapen. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact